Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.91 USD
Change Today +0.63 / 4.41%
Volume 1.8M
FOLD On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William D. Baird III

Chief Financial Officer and Secretary,Amicus Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Mr. William D. Baird, III, also known as Chip, has been the Chief Financial Officer at Amicus Therapeutics, Inc. since April 16, 2012 and also serves as its Secretary. Mr. Baird served as the Chief Financial Officer of PTC Therapeutics Inc., from May 18, 2005 to June 3, 2013, and served as its Principal Accounting Officer until June 3, 2013. Mr. Baird served as Vice President of Finance and Strategic Planning of PTC Therapeutics Inc. Previously, Mr. Baird worked at L.E.K. ...

Read Full Background

Corporate Headquarters*

1 Cedar Brook Drive
Cranbury, New Jersey 08512

United States

Phone: 609-662-2000
Fax: 609-662-2001

Board Members Memberships*

There is no Board Members Memberships data available.


University of Pennsylvania - The Wharton School
Georgetown University - Edmund A. Walsh School of Foreign Service

Other Affiliations*

Annual Compensation*

Total Annual Compensation$568,623

Stock Options*

Restricted Stock Awards$215,000
All Other Compensation$15,250
Exercised Options45,311
Exercised Options Value$166,697
Exercisable Options167,908
Exercisable Options Value$652,348
Unexercisable Options344,781
Unexercisable Options Value$1,768,213
Total Value of Options$2,587,258
Total Number of Options558,000

Total Compensation*

Total Annual Cash Compensation$583,873
Total Short Term Compensation$568,623
Other Long Term Compensation$230,250
Total Calculated Compensation$1,142,673
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FOLD:US $14.91 USD +0.63


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMICUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at